Self-monitoring of blood glucose (SMBG) is widely accepted as an integral part of the routine medical regimen of children and adolescents with diabetes. However, few guidelines pertaining to what constitutes good glycemic control in this age-group have been published. Many health-care providers have adopted the attitude that normalization of blood glucose levels should be the goal of management, although most recognize that this is virtually unobtainable, given the limitations of insulin delivery systems and variabilities in diet and physical activity. Recent data pertaining to the development of diabetic complications and the potential hazards of overtight glycemic control in the pediatric age-group indicate that it may be time to rethink the entire issue.
Most parents of diabetic children are painfully aware of the evidence that poor glycemic control increases the risk of diabetic complications. Preliminary reports from the Diabetes Control and Complications Trial have been widely publicized, and numerous studies suggesting the benefits of tight glycemic control on physiological markers and diabetic complications have appeared in both scientific publications and the lay press (1). Some parents appear to live in constant fear that even occasional high blood glucose levels will condemn their child to a life without sight, loss of limbs, or a life on kidney dialysis. Many have adopted the belief that the lower the blood glucose level the better.
Two recent studies suggest that such parental anxiety may not be justified. Kostraba et al. (2) examined the relationship between diabetic complications and duration, both before and after puberty, in three large cohorts of insulin-dependent diabetes mellitus subjects. Retinopathy, overt nephropathy, and mortality (for the same duration of diabetes) were all more prevalent in subjects diagnosed during or after puberty compared with those diagnosed before puberty. When the prepubertal years of diabetes duration were subtracted from the total duration of diabetes, however, all differences in prevalence rates disappeared. They concluded that "the contribution of the prepubertal years of diabetes to long-term prognosis may be minimal."
In this issue (p. 1034), Klein et al. report data from a prospective analysis of the relationship between the time of the first menstrual period (menarche) and diabetic retinopathy. Although the duration of diabetes, pubertal status, and diastolic blood pressure all were significant predictors of retinopathy, the duration of diabetes after menarche conferred -1.3 times the risk of retinopathy compared to duration before menarche. A similar recent study suggested that the relative risk of developing retinopathy was even greater (4.8-fold) after puberty (3). In neither study was glycemic control found to be related to retinopathy if duration was taken into account.
WHAT IS IT ABOUT ADOLESCENCE?
These data suggest that certain events occurring at the time of puberty are related to the development of microvascular complications. Glycemic control tends to deteriorate during adolescence (4); the data noted above, however, imply that other factors are also involved. Few studies have explored the interactions between the changing hormonal environment of puberty (sex steroids, growth hormone, and growth factors) and hyperglycemia. Recent work suggests that insulinlike growth factor I (IGF-I or somatomedin C), like several other growth factors, may be involved in angiogenesis and the development of atheromatous lesions, although few data pertain to alterations in growth factor produc-tion or action specifically in diabetes (5). Plasma concentrations of both growth hormone and IGF-I nearly double during normal puberty compared with childhood and adulthood (6, 7) , probably under the influence of increased gonadal steroid secretions (8) . Diabetic children in poor glycemic control may have poor growth and delayed puberty; frequently, they also have low serum concentrations of gonadal steroids and IGF-I for chronological age (9) . Tight glycemic control in these subjects commonly corrects these hormonal factors (10) and stimulates progression of growth and puberty, and rapidly progressive retinopathy occasionally occurs (11) . Some investigators have postulated a direct relationship between IGF-I and diabetic retinopathy (12) . In addition, hypophysectomy, which reduces both growth hormone and IGF-I levels, has been associated in anecdotal and uncontrolled studies with improvement in proliferative retinopathy. Taken together, these data suggest that hyperglycemia and the hormonal milieu of puberty are a sinister combination. It may be overly simplistic to conclude from these data that hyperglycemia before puberty (when the hypothalamo-pituitarygonadal axis is relatively quiescent) is innocuous, whereas hyperglycemia during or after puberty is dangerous. On the other hand, available data suggest that pubertal status is perhaps an even more important determinant of diabetic complications than glycemic control.
ever, the frequency of asymptomatic blood glucose determinations <2.8 mM, found on routine SMBG, correlated inversely with scores of abstract/visual reasoning.
These studies present compelling evidence that the young child with diabetes is at particular risk for developing subtle neurological impairments that may be associated with or caused by hypoglycemia. This actually comes as no surprise. Similar age-dependent neurological deficits have been observed in children with endogenous hyperinsulinism (19) , which suggests that the developing brain is more susceptable to hypoglycemia than that of the older child or adult. Alternatively, hypoglycemia might simply be more severe or prolonged in young children, who generally are less likely to identify the somatic signals of hypoglycemia, resulting in delayed behavior (eating or notifying parents) directed toward terminating the hypoglycemic event. Little is known about glucose counterregulation in young children; epinephrine and glucagon counterregulatory responses to hypoglycemia may be poorly developed. Possibly, a combination of factors is involved. Whatever the mechanism, it seems clear that subtle neuropsychological dysfunction represents a most troublesome and possibly highly prevalent disease complication in diabetic children today, especially those diagnosed at a young age.
DARK SIDE OF TIGHT CONTROL
Are there hazards associated with the current management practices of children with diabetes and, if so, are any of them avoidable? Almost three decades ago, Ack et al. (13) reported lower IQ scores in children diagnosed with diabetes before 5 yr of age compared with nondiabetic siblings. More recently, several investigators observed a high prevalence of EEG abnormalities in early-onset diabetic children (14) , and some have suggested a relationship with previous bouts of severe hypoglycemia (15) . With a battery of neuropsychological tests, Ryan et al. (16) detected subtle but significant abnormalities in crystalline intelligence (reading, spelling, verbal skills) related to duration of diabetes. Additional abnormalities in fluid intelligence (visual memory and visual-spatial), suggestive of right hemisphere dysfunction, were found in those whose diabetes was diagnosed before 4 yr of age. Other studies have confirmed this distinctive array of neuropsychological abnormalities in children diagnosed with diabetes before 4 or 5 yr of age (17) . In an attempt to determine the factors involved in this age-dependent phenomenon, Golden et al. (18) followed 23 children with insulindependent diabetes mellitus, diagnosed before 5 yr of age, for 6-78 mo. Neither HbA, values nor frequency of severe symptomatic hypoglycemia were associated with abnormalities on neuropsychological testing. How-
IS THERE A DIFFERENCE BETWEEN GOOD AND SAFE CONTROL?
What are reasonable medical guidelines for children and adolescents with diabetes? Are we to abandon intensive insulin therapy, avoiding hypoglycemia at all costs? Is it sufficient simply to avoid polyuria and ketoacidosis? Will this allow normal growth and development?
First, it should be emphasized that the relationship between hypoglycemia and neuropsychological abnormalities is circumstantial: the cause-and-effect loop is not fully closed. No one has demonstrated that the avoidance of hypoglycemia in the young diabetic child will prevent neuropsychological abnormalities. Second, it seems both ironic and frustrating that tight control is most easily achieved in early childhood, and that this task becomes increasingly difficult during adolescence. Given the fact that adolescence is a stage characterized normally by rebellion, testing of limits, and struggling for independence from parents, what clinician would glibly recommend the sudden imposition of tight glycemic control to the diabetic adolescent after years of laissez-faire management during childhood? Bad habits are tough to break, especially so for the adolescent with diabetes.
Given the current state of affairs, complete normalization of blood glucose levels for the young child with diabetes seems both unrealistic and dangerous. Consci-entious efforts to achieve preprandial blood glucose levels at 5.6-6.7 mM (100-120 mg/dl) in this age-group usually will ensure frequent blood glucose levels of <3.4 mM (60 mg/dl). Perhaps safer management goals should include greater attention to the prevention of asymptomatic hypoglycemia, decreasing the frequency of hospitalizations for hypoglycemia and ketoacidosis, and promoting normal growth and development. For the preschooler, a target blood glucose level of 8.4 mM (150 mg/dl), with diligent attempts to avoid readings <4.5 mM (80 mg/dl), seems reasonable. During later childhood, and certainly during adolescence, attempts at near normalization of blood glucose levels are easier to justify. Attention to glycemic control and the continued use of SMBG in children with diabetes seem as warranted and valuable as ever, provided that age-dependent glycemic guidelines are considered.
The relationship between hyperglycemia and microvascular complications is as firmly established in the minds of many parents of children with diabetes as is the relationship between smoking and lung cancer. Both parents and health-care providers alike must understand that there are few hard scientific data linking hyperglycemia before puberty to complications. On the other hand, hypoglycemia may very well produce subtle but serious neurological complications. Given these insights, now is the time to reevaluate our management recommendations for children, recognizing that parents may need additional encouragement to translate these recommendations into altered behavior.
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